Pulse Biosciences, Inc.

PLSENASDAQHealthcare● Active

$25.71

+$0.38(+1.48%)

Market Cap$1.8B

P/E Ratio—

52W High$27.98

52W Low$12.56

Avg Volume301K

Open$25.59

Beta1.66

Insider Trades Ownership Employees

Pulse Biosciences, Inc. (PLSE) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · PLSE · as of Jun 8, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.27

Buy/Sell (by trades)

Overall sentiment

BEARISH

↑ Buy 21%Active transactions only · RSU vesting excluded79% Sell ↓

Pulse Biosciences, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

PLSE insider buying and selling by quarter

PLSE insider selling · PLSE insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

8.9M4.4M0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · PLSE ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

PLSE executive sell shares · PLSE board member insider trading · PLSE insider trading SEC filing

Showing 54 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
May 11, 2026	LAVIOLETTE PAUL A CEO · Director	Purchase	15,000	$19.69	$295K	15,000	Form 4
May 11, 2026	DUGGAN ROBERT W Director	Purchase	660,233	$19.69	$13.00M⚡	48,211,433	Form 4
Feb 18, 2026	Danahy Kevin Patrick Chief Commercial Officer	Option	5,000	$1.53	$8K	48,298	Form 4
Feb 18, 2026	Danahy Kevin Patrick Chief Commercial Officer	Sale	5,000	$23.64	$118K	43,298	Form 4
Feb 17, 2026	Danahy Kevin Patrick Chief Commercial Officer	Option	20,000	$1.53	$31K	63,298	Form 4
Feb 12, 2026	Danahy Kevin Patrick Chief Commercial Officer	Sale	20,000	$23.37	$467K	43,298	Form 4
Feb 13, 2026	Danahy Kevin Patrick Chief Commercial Officer	Sale	20,000	$23.53	$471K	43,298	Form 4
Feb 17, 2026	Danahy Kevin Patrick Chief Commercial Officer	Sale	20,000	$23.63	$473K	43,298	Form 4
Feb 11, 2026	Danahy Kevin Patrick Chief Commercial Officer	Option	20,000	$1.53	$31K	63,298	Form 4
Feb 10, 2026	Danahy Kevin Patrick Chief Commercial Officer	Sale	20,000	$23.52	$470K	43,298	Form 4
Feb 9, 2026	Danahy Kevin Patrick Chief Commercial Officer	Sale	20,000	$21.45	$429K	43,298	Form 4
Feb 11, 2026	Danahy Kevin Patrick Chief Commercial Officer	Sale	20,000	$25.20	$504K	43,298	Form 4
Oct 2, 2025	Danahy Kevin Patrick Chief Commercial Officer	Option	4,600	$1.53	$7K	47,898	Form 4
Oct 2, 2025	Danahy Kevin Patrick Chief Commercial Officer	Sale	4,600	$18.53	$85K	43,298	Form 4
Sep 18, 2025	Danahy Kevin Patrick Chief Commercial Officer	Option	20,000	$1.53	$31K	63,298	Form 4
Sep 19, 2025	Danahy Kevin Patrick Chief Commercial Officer	Option	400	$1.53	$612	43,698	Form 4
Sep 19, 2025	Danahy Kevin Patrick Chief Commercial Officer	Sale	400	$18.48	$7K	43,298	Form 4
Sep 18, 2025	Danahy Kevin Patrick Chief Commercial Officer	Sale	20,000	$18.49	$370K	43,298	Form 4
Sep 17, 2025	UECKER DARRIN CTO · Director	Option	100,000	$4.00	$400K	284,406	Form 4
Sep 17, 2025	UECKER DARRIN CTO · Director	Option	61,534	$4.00	$246K	184,406	Form 4
Sep 16, 2025	UECKER DARRIN CTO · Director	Option	25,000	$4.00	$100K	147,872	Form 4
Sep 17, 2025	UECKER DARRIN CTO · Director	Option	20,000	$4.00	$80K	142,872	Form 4
Sep 16, 2025	UECKER DARRIN CTO · Director	Sale	25,000	$16.28	$407K	122,872	Form 4
Sep 17, 2025	UECKER DARRIN CTO · Director	Sale	20,000	$16.21	$324K	122,872	Form 4
Sep 15, 2025	UECKER DARRIN CTO · Director	Option	25,000	$4.00	$100K	147,872	Form 4

LAVIOLETTE PAUL A

CEO · Director

Purchase

Date

May 11

15,000

Price

$19.69

Value

$295K

View Form 4 on SEC.gov

DUGGAN ROBERT W

Director

Purchase

Date

May 11

660,233

Price

$19.69

Value

$13.00M ⚡

View Form 4 on SEC.gov

Danahy Kevin Patrick

Chief Commercial Officer

Option

Date

Feb 18

5,000

Price

$1.53

Value

$8K

View Form 4 on SEC.gov

Danahy Kevin Patrick

Chief Commercial Officer

Sale

Date

Feb 18

5,000

Price

$23.64

Value

$118K

View Form 4 on SEC.gov

Danahy Kevin Patrick

Chief Commercial Officer

Option

Date

Feb 17

20,000

Price

$1.53

Value

$31K

View Form 4 on SEC.gov

Danahy Kevin Patrick

Chief Commercial Officer

Sale

Date

Feb 12

20,000

Price

$23.37

Value

$467K

View Form 4 on SEC.gov

Danahy Kevin Patrick

Chief Commercial Officer

Sale

Date

Feb 13

20,000

Price

$23.53

Value

$471K

View Form 4 on SEC.gov

Danahy Kevin Patrick

Chief Commercial Officer

Sale

Date

Feb 17

20,000

Price

$23.63

Value

$473K

View Form 4 on SEC.gov

Danahy Kevin Patrick

Chief Commercial Officer

Option

Date

Feb 11

20,000

Price

$1.53

Value

$31K

View Form 4 on SEC.gov

Danahy Kevin Patrick

Chief Commercial Officer

Sale

Date

Feb 10

20,000

Price

$23.52

Value

$470K

View Form 4 on SEC.gov

Danahy Kevin Patrick

Chief Commercial Officer

Sale

Date

Feb 9

20,000

Price

$21.45

Value

$429K

View Form 4 on SEC.gov

Danahy Kevin Patrick

Chief Commercial Officer

Sale

Date

Feb 11

20,000

Price

$25.20

Value

$504K

View Form 4 on SEC.gov

Danahy Kevin Patrick

Chief Commercial Officer

Option

Date

Oct 2

4,600

Price

$1.53

Value

$7K

View Form 4 on SEC.gov

Danahy Kevin Patrick

Chief Commercial Officer

Sale

Date

Oct 2

4,600

Price

$18.53

Value

$85K

View Form 4 on SEC.gov

Danahy Kevin Patrick

Chief Commercial Officer

Option

Date

Sep 18

20,000

Price

$1.53

Value

$31K

View Form 4 on SEC.gov

Danahy Kevin Patrick

Chief Commercial Officer

Option

Date

Sep 19

400

Price

$1.53

Value

$612

View Form 4 on SEC.gov

Danahy Kevin Patrick

Chief Commercial Officer

Sale

Date

Sep 19

400

Price

$18.48

Value

$7K

View Form 4 on SEC.gov

Danahy Kevin Patrick

Chief Commercial Officer

Sale

Date

Sep 18

20,000

Price

$18.49

Value

$370K

View Form 4 on SEC.gov

UECKER DARRIN

CTO · Director

Option

Date

Sep 17

100,000

Price

$4.00

Value

$400K

View Form 4 on SEC.gov

UECKER DARRIN

CTO · Director

Option

Date

Sep 17

61,534

Price

$4.00

Value

$246K

View Form 4 on SEC.gov

UECKER DARRIN

CTO · Director

Option

Date

Sep 16

25,000

Price

$4.00

Value

$100K

View Form 4 on SEC.gov

UECKER DARRIN

CTO · Director

Option

Date

Sep 17

20,000

Price

$4.00

Value

$80K

View Form 4 on SEC.gov

UECKER DARRIN

CTO · Director

Sale

Date

Sep 16

25,000

Price

$16.28

Value

$407K

View Form 4 on SEC.gov

UECKER DARRIN

CTO · Director

Sale

Date

Sep 17

20,000

Price

$16.21

Value

$324K

View Form 4 on SEC.gov

UECKER DARRIN

CTO · Director

Option

Date

Sep 15

25,000

Price

$4.00

Value

$100K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About PLSE insider trading

PLSE insider trades

Pulse Biosciences, Inc. (PLSE) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Danahy Kevin Patrick (Chief Commercial Officer), UECKER DARRIN (CTO · Director), DUGGAN ROBERT W (Director). Over the past 12 months, 4 insiders have filed transactions with the SEC. PLSE insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Pulse Biosciences, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

PLSE insider trading · 5 questions

The insiders of Pulse Biosciences, Inc. (PLSE) include executives and directors such as Danahy Kevin Patrick (Chief Commercial Officer), UECKER DARRIN (CTO · Director), DUGGAN ROBERT W (Director), among others. Over the past 12 months, 4 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

PLSE board member insider tradingwho are PLSE insidersPLSE insider rosterPulse Biosciences, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026